Drugs and biologicals
Ended Purchase Order Awarded Last action
- Contract number
- HHSN268201300097P
- Awardee
-
Gentian Usa, Inc. UEI DQCKKLFV5243
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $8,665
Award facts
- Contract value 100% obligated
- $8,665.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Framingham, MA 01702, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$450 | |
| Original award | $9,115 |
Quick answers
Who was awarded contract HHSN268201300097P?
HHSN268201300097P was awarded to Gentian Usa, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on April 1, 2013.
How much is contract HHSN268201300097P worth?
The government has obligated $8,665 on HHSN268201300097P.
Was contract HHSN268201300097P competed?
The extent of competition for HHSN268201300097P was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award